Definitive Healthcare Net Income Over Time
| DH Stock | USD 2.05 0.12 5.53% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Definitive Healthcare Performance and Definitive Healthcare Correlation. Definitive | Build AI portfolio with Definitive Stock |
Is there potential for Health Care Technology market expansion? Will Definitive introduce new products? Factors like these will boost the valuation of Definitive Healthcare. Projected growth potential of Definitive fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Definitive Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Definitive Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Definitive Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Definitive Healthcare and related stocks such as National Research Corp, TruBridge, and Spok Holdings Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRC | 514 K | 11.6 M | 15.1 M | 15.5 M | 18.2 M | 17.6 M | 20.5 M | 22.9 M | 30 M | 32.4 M | 37.3 M | 37.5 M | 31.8 M | 31 M | 24.8 M | 11.6 M | 14.3 M |
| TBRG | 4.9 M | 25.8 M | 30 M | 32.7 M | 32.9 M | 18.3 M | 3.9 M | (17.1 M) | 17 M | 20.5 M | 14.2 M | 18.4 M | 15.9 M | (45.8 M) | (20.4 M) | (18.4 M) | (17.5 M) |
| SPOK | (309.8 M) | 88.6 M | 32 M | 27.5 M | 20.7 M | 84.2 M | 14 M | (15.3 M) | (1.5 M) | (10.8 M) | (44.2 M) | (22.2 M) | 21.9 M | 15.7 M | 15 M | 17.2 M | 18.1 M |
| NAKA | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | (2.5 M) | (1.6 M) | (3.6 M) | (3.3 M) | (3.1 M) |
| SOPH | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (33.8 M) | (39.3 M) | (73.7 M) | (87.4 M) | (79 M) | (62.5 M) | (56.2 M) | (59.1 M) |
| KYTX | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (28.9 M) | (60.4 M) | (127.5 M) | (114.7 M) | (109 M) |
| EDIT | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (13.7 M) | (72.9 M) | (97.2 M) | (120.3 M) | (110 M) | (133.7 M) | (109.4 M) | (185.1 M) | (204.4 M) | (153.2 M) | (237.1 M) | (213.4 M) | (202.7 M) |
| CABA | (250 K) | (250 K) | (250 K) | (250 K) | (250 K) | (250 K) | (250 K) | (250 K) | (12.2 M) | (15.1 M) | (32.5 M) | (45.5 M) | (51.8 M) | (67.7 M) | (115.9 M) | (104.3 M) | (99.1 M) |
| SLP | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 5.8 M | 8.9 M | 8.6 M | 9.3 M | 9.8 M | 12.5 M | 10 M | 10 M | (64.7 M) | (58.2 M) | (55.3 M) |
Definitive Healthcare and related stocks such as National Research Corp, TruBridge, and Spok Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Definitive Healthcare financial statement analysis. It represents the amount of money remaining after all of Definitive Healthcare Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Definitive Healthcare Corp | DH |
| Classification | Health Management |
| Business Address | 492 Old Connecticut |
| Exchange | NASDAQ Exchange |
USD 2.05
Check out Definitive Healthcare Performance and Definitive Healthcare Correlation. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Definitive Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.